<法規>
<法規性質>命令</法規性質>
<英文法規名稱>Food Safety Risk Assessment Advisory Committee Establishment Regulations</英文法規名稱>
<中文法規名稱>食品風險評估諮議會設置辦法</中文法規名稱>
<法規網址>https://law.moj.gov.tw/Eng/LawClass/LawContent.aspx?PCODE=L0000060</法規網址>
<最新英文異動日期>20140724</最新英文異動日期>
<廢止註記>
</廢止註記>
<附件 />
<沿革內容><![CDATA[1.MOHW Food No. 1021151753 promulgated on January 10, 2014
2.MOHW Food No. 1031301854 Amended and promulgated on July 24, 2014]]></沿革內容>
<前言><![CDATA[]]></前言>
<法規內容>
  <條文>
    <條號>Article 1</條號>
    <條文內容><![CDATA[The Regulations are stipulated and issued under Paragraph 4 of Article 4 of the Act Governing Food Safety and Sanitation (hereinafter referred to as “the Act”).
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 2</條號>
    <條文內容><![CDATA[In the Regulations, the term “risk assessment” of food safety, shall be based on scientific data, as depicted in accordance with hazard identification, hazard characterization, exposure assessment, and risk characterization.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 3</條號>
    <條文內容><![CDATA[The mission of the Food Safety Risk Assessment Advisory Committee (hereinafter referred to as “the Committee”) is to perform consultation and recommendation on food safety risk assessment based on the principles of scientific evidence, precaution, and information transparency, relating to the following matters:
1.Risk assessment on food safety and related hazardous substances.
2.Policy determination and strategy setting.
3.Program deliberation.
4.Amendment of guidelines.
5.Operation implementation.
6.Related promotional activities.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 4</條號>
    <條文內容><![CDATA[The Committee is made up of 15 ~ 19 members as appointed by the Minister of the Health and Welfare (hereinafter referred to as the “Minister”), which consists of experts and scholars specializing in food safety, toxicology and risk assessment, and representatives of civil societies in related domains.
With regard to the members of the Committee in the preceding paragraph, the quorum of either gender shall not be less than one-third of the total number of its members. The Committee must include a convener and a vice-convener, as appointed by the Minister.
A member of the Committee will be appointed for a term of 3 years, with eligibility for reappointment. Those members who are unable to complete the term prescribed above for whatever reasons may be additionally appointed as adjunct members, which the term of the successor will be ended as the term of its predecessor.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 5</條號>
    <條文內容><![CDATA[The affairs and tasks of the Committee shall be performed by the executive secretary and designated workers as appointed by the Minister from the personnel of the Food and Drug Administration (hereinafter referred to as the “FDA”).
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 6</條號>
    <條文內容><![CDATA[A meeting shall be held semiannually, and an interim meeting may be convened as deemed necessary. The meeting requires the attendance of at least half of the members in order to commence.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 7</條號>
    <條文內容><![CDATA[The convener shall be the chairperson, and the vice-convener may be the acting chairperson if the convener fails to attend the meeting. When both convener and vice-convener fail to attend the meeting, the convener may designate one of members as the chairperson, or in a situation where the convener is unable to designate, the chairperson may be elected by all attending members.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 8</條號>
    <條文內容><![CDATA[The Administrative Procedure Act shall apply to the avoidance affairs for the members of the Committee.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 9</條號>
    <條文內容><![CDATA[The meeting may, when necessary, invite guest delegation of experts, scholars, representatives of agencies and groups, as well as authorities of the FDA to attend.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 10</條號>
    <條文內容><![CDATA[The members and participants attending the meetings shall not disclose any information about the meeting minutes, members’ opinion as shared, or any remarks concluded, in any means pursuant to the duty of confidentiality.
Any information related to the meeting as mentioned in the preceding paragraph may only be made available to the public after being approved by the FDA under administrative procedures.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 11</條號>
    <條文內容><![CDATA[Members of the Committee shall exercise its functions independently, free from any interference.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 12</條號>
    <條文內容><![CDATA[The Regulations shall be implemented on the date of promulgation.
]]></條文內容>
  </條文>
</法規內容>
</法規>
